TNFSF10 and neoplasm: To evaluate the anti-tumour growth capacity of ZD55-TRAIL in vivo, subcutaneous xenografts established by A549 sphere cells in nude mice were treated with PBS, ZD55-EGFP or ZD55-TRAIL respectively.